Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer

被引：19
|
作者：
Comella, P [1 ]
机构：
[1] Natl Tumor Inst, Div Med Oncol A, I-80131 Naples, Italy
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 02期
关键词：
D O I：
10.1016/S0093-7754(01)90271-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 10
页数：4
相关论文
共 50 条
  • [11] Gemcitabine and vinorelbine in advanced non-small cell lung cancer
    Vazquez, F
    Cueva, JF
    Baron, FJ
    Candamio, S
    Calvo, M
    Irigoyen, A
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [12] Gemcitabine-cisplatin-vinorelbine phase II trial in stage III non small cell lung cancer
    Cueva, JF
    Grande, C
    Firvida, J
    Amenedo, M
    Lázaro, M
    Romero, C
    Quintero, G
    Huidobro, G
    García, J
    Barón, FJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S259 - S259
  • [13] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [14] Cisplatin, Gemcitabine and paclitaxel in advanced non-small cell lung cancer. A phase I study
    Comella, P
    Frasci, G
    Panza, N
    Lorusso, V
    Nicolella, GP
    Natale, M
    Manzione, L
    Bilancia, D
    Cioffi, R
    Maiorino, L
    Apicella, A
    Gravina, A
    Ruffolo, P
    De Rosa, V
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [15] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    S Niho
    K Kubota
    K Goto
    H Ohmatsu
    T Matsumoto
    R Kakinuma
    Yutaka Nishiwaki
    British Journal of Cancer, 2002, 87 : 1360 - 1364
  • [16] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    Niho, S
    Kubota, K
    Goto, K
    Ohmatsu, H
    Matsumoto, T
    Kakinuma, R
    Nishiwaki, Y
    BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1360 - 1364
  • [17] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [18] Prospective randomized phase III trial of triplet chemotherapy with paclitaxel plus gemcitabine plus cisplatin compared to standard doublet chemotherapy with vinorelbine plus cisplatin in advanced non-small cell lung cancer
    Sorensen, J.
    Hansen, O.
    Vilmar, A.
    Frank, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [19] Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trial
    Comella, P
    Panza, N
    Nicolella, GP
    Manzione, L
    Lorusso, V
    Cioffi, R
    Decataldis, G
    Maiorino, L
    Bilancia, D
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S247 - S247
  • [20] Comparative costs of gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of non-small cell lung cancer in Germany
    Bischoff, H
    Hamann, M
    Stynes, G
    Bhalla, S
    Tilden, D
    Kielhorn, A
    VALUE IN HEALTH, 2004, 7 (06) : 674 - 674
12345